Privilège Ventures SA is a seed and early stage venture capital firm. We take an active, hands-on approach that leverages our entrepreneurial expertise. We partner with entrepreneurs to create a sustainable and scalable business. We proudly launched our CEO Scouting Program involving some of the best entrepreneurs we met over the years.
Location: Switzerland, Ticino, Lugano
Employees: 1-10
Founded date: 2021
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 03.03.2026 | Xsensio | xsensio.com | $11.59M | Switzerlan... |
| 15.07.2022 | Wyth™ | wyth.live | $1.63M | Switzerlan... |
| 18.01.2022 | INERGIO | inergio.ch | $1.37M | Switzerlan... |
Mentions in press and media 28
| Date | Title | Description |
| 05.03.2026 | Xsensio Secures $7M to Propel Real-Time Wearable Biosensing into Clinical Practice | Xsensio secured $7M Series A funding. This investment propels its innovative "Lab-on-Skin" wearable biosensing platform forward. The system delivers continuous, real-time biochemical data directly from the body. It monitors crucia... |
| 03.03.2026 | Xsensio’s wearable chip that analyses proteins and hormones in real time draws €6 million | Xsensio, a Lausanne-based DeepTech company developing near real-time continuous biochemical monitoring, announced the successful closing of a €6 million ($7 million) oversubscribed Series A financing round. The round was led by VC firm WI H... |
| 03.03.2026 | Xsensio: $7 Million Raised In Series A To Advance Continuous Biochemical Monitoring Platform | Xsensio SA, a Swiss deep-tech company focused on near-real-time continuous biochemical monitoring, announced the closing of a $7 million oversubscribed Series A financing round to accelerate the clinical deployment of its wearable biosensin... |
| 02.03.2026 | Oversubscribed $7M Series A to boost Xsensio biosensing clinical deployment | Xsensio develops the Lab-on-Skin wearable biosensing platform to deliver continuous, real-time biochemical information for personalized and preventive healthcare. Designed for multiparametric analysis, its ultra-miniaturized chip integrate... |
| 27.06.2024 | CHF1.8 million to eliminate critical bottlenecks in traditional drug development | ENANTIOS technology, developed over a five-year research project at ETH Zurich, enables the complete characterization of complex molecules and aspects of the three dimensional structure which are not possible to resolve with other methods.... |
| 01.03.2023 | Interview with Aike Festini: Integrity, authenticity, and the lessons learned from failure | Interview with Aike Festini: Integrity, authenticity, and the lessons learned from failure 01.03.2023 06:00, Morgane Ghilardi linkedIn facebook twitter instagram youtube --> Statistically, a startup is much more likely to fold than to su... |
| 06.01.2023 | Privilège Ventures Launches Fund for Female Led Startups | The Swiss-based venture capital firm will invest in female founders with its CHF 20 million Fund IV; “We don’t just want to support women,” said Privilège’s Jacqueline Ruedin Rüsch. “The data shows women in the driver’s seat produce better ... |
| 07.11.2022 | Privilège Ventures Launches Fund for Female Led Startups | Privilège Ventures, a Lugano, Switzerland-based venture capital firm, launched CHF 20m Fund IV, dedicated to scouting and investing in female led early-stage startups across Europe. Fund IV will seek 15-20 seed and early-stage female led co... |
| 03.11.2022 | Privilège Ventures launches $20M fund investing in women-led startups | Lugano, Switzerland-based venture capital fund Privilège Ventures just launched its fourth fund. The CHF 20 million (just over $20 million) fund is earmarked for women-led early-stage startups across Europe. “We don’t just want to support w... |
| 03.11.2022 | The Swiss-based VC Privilège Ventures Launches Fund for Female-Led Startups | The Swiss-based venture capital firm will invest in female founders with its CHF 20 million Fund IV. We don’t just want to support women. The data shows women in the driver’s seat produce better ROI. said Privilège’s Jacqueline Ruedin Rüs... |
Show more